Amiodarone-induced thyroid dysfunction
- PMID: 24067547
- DOI: 10.1177/0885066613503278
Amiodarone-induced thyroid dysfunction
Abstract
Amiodarone is an effective medication for the treatment of cardiac arrhythmias. Originally developed for the treatment of angina, it is now the most frequently prescribed antiarrhythmia drug despite the fact that its use is limited because of potential serious side effects including adverse effects on the thyroid gland and thyroid hormones. Although the mechanisms of action of amiodarone on the thyroid gland and thyroid hormone metabolism are poorly understood, the structural similarity of amiodarone to thyroid hormones, including the presence of iodine moieties on the inner benzene ring, may play a role in causing thyroid dysfunction. Amiodarone-induced thyroid dysfunction includes amiodarone-induced thyrotoxicosis (AIT) and amiodarone-induced hypothyroidism (AIH). The AIT develops more commonly in iodine-deficient areas and AIH in iodine-sufficient areas. The AIT type 1 usually occurs in patients with known or previously undiagnosed thyroid dysfunction or goiter. The AIT type 2 usually occurs in normal thyroid glands and results in destruction of thyroid tissue caused by thyroiditis. This is the result of an intrinsic drug effect from the amiodarone itself. Mixed types are not uncommon. Patients with cardiac disease receiving amiodarone treatment should be monitored for signs of thyroid dysfunction, which often manifest as a reappearance of the underlying cardiac disease state. When monitoring patients, initial tests should include the full battery of thyroid function tests, thyroid-stimulating hormone, thyroxine, triiodothyronine, and antithyroid antibodies. Mixed types of AIT can be challenging both to diagnose and treat and therapy differs depending on the type of AIT. Treatment can include thionamides and/or glucocorticoids. The AIH responds favorably to thyroid hormone replacement therapy. Amiodarone is lipophilic and has a long half-life in the body. Therefore, stopping the amiodarone therapy usually has little short-term benefit.
Keywords: T3; amiodarone-induced thyrotoxicosis; heart; hyperthyroidism; hypothyroidism; thyroid hormone; thyrotoxicosis; triiodothyronine.
© The Author(s) 2013.
Similar articles
-
[Amiodarone and the thyroid gland].Postepy Hig Med Dosw (Online). 2004 Apr 20;58:216-25. Postepy Hig Med Dosw (Online). 2004. PMID: 15114257 Review. Polish.
-
Amiodarone and the thyroid.Endokrynol Pol. 2015;66(2):176-86. doi: 10.5603/EP.2015.0025. Endokrynol Pol. 2015. PMID: 25931048 Review.
-
Approach to the patient with amiodarone-induced thyrotoxicosis.J Clin Endocrinol Metab. 2010 Jun;95(6):2529-35. doi: 10.1210/jc.2010-0180. J Clin Endocrinol Metab. 2010. PMID: 20525904 Review.
-
[Amiodarone-induced thyrotoxicosis].G Ital Cardiol (Rome). 2017 Mar;18(3):219-229. doi: 10.1714/2674.27399. G Ital Cardiol (Rome). 2017. PMID: 28398380 Review. Italian.
-
The effects of amiodarone on the thyroid.Endocr Rev. 2001 Apr;22(2):240-54. doi: 10.1210/edrv.22.2.0427. Endocr Rev. 2001. PMID: 11294826 Review.
Cited by
-
Facile access to benzofuran derivatives through radical reactions with heteroatom-centered super-electron-donors.Nat Commun. 2023 Nov 15;14(1):7381. doi: 10.1038/s41467-023-43198-y. Nat Commun. 2023. PMID: 37968279 Free PMC article.
-
Hyperthyroidism and the Risk of Cardiac Arrhythmias: A Narrative Review.Cureus. 2022 Apr 22;14(4):e24378. doi: 10.7759/cureus.24378. eCollection 2022 Apr. Cureus. 2022. PMID: 35619859 Free PMC article. Review.
-
Amiodarone-Induced Multi-Systemic Toxicity Involving the Liver, Lungs, Thyroid, and Eyes: A Case Report.Front Cardiovasc Med. 2022 Feb 28;9:839441. doi: 10.3389/fcvm.2022.839441. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35295268 Free PMC article.
-
Atypical Thyroid Function Tests and Thyroid Hormone Resistance.Cureus. 2021 Jul 12;13(7):e16328. doi: 10.7759/cureus.16328. eCollection 2021 Jul. Cureus. 2021. PMID: 34306893 Free PMC article.
-
Clinical Efficacy and Safety of Shensong Yangxin Capsule-Amiodarone Combination on Heart Failure Complicated by Ventricular Arrhythmia: A Meta-Analysis of Randomized Controlled Trials.Front Pharmacol. 2021 Feb 22;12:613922. doi: 10.3389/fphar.2021.613922. eCollection 2021. Front Pharmacol. 2021. PMID: 33692689 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
